Crossref
26-A-13705-ACC ZALUNFIBAN REDUCES SIZE OF ST SEGMENT ELEVATION MYOCARDIAL INFARCTION: THE CELEBRATE TRIAL
JACC · 2026-04 · 87 (13) · A854
DOI: 10.1016/j.jacc.2026.02.2113 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von James L. Januzzi und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Januzzi, J. L., Gibson, C. M., Coller, B., Granger, C. B., Montalescot, G., Berg, J. M. T., & Hof, A. V. T. (2026). 26-A-13705-ACC ZALUNFIBAN REDUCES SIZE OF ST SEGMENT ELEVATION MYOCARDIAL INFARCTION: THE CELEBRATE TRIAL. JACC, 87(13), A854. https://doi.org/10.1016/j.jacc.2026.02.2113
Vancouver
Januzzi JL, Gibson CM, Coller B, Granger CB, Montalescot G, Berg JMT, et al. 26-A-13705-ACC ZALUNFIBAN REDUCES SIZE OF ST SEGMENT ELEVATION MYOCARDIAL INFARCTION: THE CELEBRATE TRIAL. JACC. 2026;87(13):A854. doi:10.1016/j.jacc.2026.02.2113
BibTeX
@article{Januzzi2026,
author = {Januzzi, James L. and Gibson, C. Michael and Coller, Barry and Granger, Christopher B. and Montalescot, Gilles and Berg, Jurrien M. Ten and Hof, Arnoud van 't},
title = {26-A-13705-ACC ZALUNFIBAN REDUCES SIZE OF ST SEGMENT ELEVATION MYOCARDIAL INFARCTION: THE CELEBRATE TRIAL},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A854},
doi = {10.1016/j.jacc.2026.02.2113}
}
EUVIMED